vs
高露洁棕榄（CL）与CSX Corporation（CSX）财务数据对比。点击上方公司名可切换其他公司
高露洁棕榄的季度营收约是CSX Corporation的1.5倍（$5.3B vs $3.5B），CSX Corporation净利率更高（23.2% vs 12.1%，领先11.0%），高露洁棕榄同比增速更快（8.4% vs 1.7%），CSX Corporation自由现金流更多（$793.0M vs $609.0M），过去两年高露洁棕榄的营收复合增速更高（2.6% vs -3.0%）
高露洁棕榄是总部位于美国纽约市曼哈顿中城公园大道的跨国消费品企业，主营家居清洁、医疗护理、个人护理、宠物护理等品类产品的生产、分销及相关服务，旗下产品行销全球多地，在日用消费领域拥有广泛的市场认可度。
CSX运输是美国一级货运铁路企业，业务覆盖美国东部区域及加拿大安大略省、魁北克省，运营铁路总里程约3.4万公里，隶属于总部位于佛罗里达州杰克逊维尔市的财富500强企业CSX Corporation，是其旗下核心子公司。
CL vs CSX — 直观对比
营收规模更大
CL
是对方的1.5倍
$3.5B
营收增速更快
CL
高出6.7%
1.7%
净利率更高
CSX
高出11.0%
12.1%
自由现金流更多
CSX
多$184.0M
$609.0M
两年增速更快
CL
近两年复合增速
-3.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.3B | $3.5B |
| 净利润 | $646.0M | $807.0M |
| 毛利率 | 60.6% | — |
| 营业利润率 | 18.1% | 36.0% |
| 净利率 | 12.1% | 23.2% |
| 营收同比 | 8.4% | 1.7% |
| 净利润同比 | -6.4% | 24.9% |
| 每股收益（稀释后） | $0.80 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLCSX
| Q1 26 | $5.3B | $3.5B | ||
| Q4 25 | $5.2B | $3.5B | ||
| Q3 25 | $5.1B | $3.6B | ||
| Q2 25 | $5.1B | $3.6B | ||
| Q1 25 | $4.9B | $3.4B | ||
| Q4 24 | $4.9B | $3.5B | ||
| Q3 24 | $5.0B | $3.6B | ||
| Q2 24 | $5.1B | $3.7B |
净利润CLCSX
| Q1 26 | $646.0M | $807.0M | ||
| Q4 25 | $-36.0M | $720.0M | ||
| Q3 25 | $735.0M | $694.0M | ||
| Q2 25 | $743.0M | $829.0M | ||
| Q1 25 | $690.0M | $646.0M | ||
| Q4 24 | $738.0M | $720.0M | ||
| Q3 24 | $737.0M | $894.0M | ||
| Q2 24 | $731.0M | $963.0M |
毛利率CLCSX
| Q1 26 | 60.6% | — | ||
| Q4 25 | 60.2% | — | ||
| Q3 25 | 59.4% | — | ||
| Q2 25 | 60.1% | — | ||
| Q1 25 | 60.8% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 60.6% | — |
营业利润率CLCSX
| Q1 26 | 18.1% | 36.0% | ||
| Q4 25 | 1.7% | 31.6% | ||
| Q3 25 | 20.6% | 30.3% | ||
| Q2 25 | 21.1% | 35.9% | ||
| Q1 25 | 21.9% | 30.4% | ||
| Q4 24 | 21.5% | 30.8% | ||
| Q3 24 | 21.2% | 37.4% | ||
| Q2 24 | 21.6% | 39.1% |
净利率CLCSX
| Q1 26 | 12.1% | 23.2% | ||
| Q4 25 | -0.7% | 20.5% | ||
| Q3 25 | 14.3% | 19.3% | ||
| Q2 25 | 14.5% | 23.2% | ||
| Q1 25 | 14.1% | 18.9% | ||
| Q4 24 | 14.9% | 20.3% | ||
| Q3 24 | 14.6% | 24.7% | ||
| Q2 24 | 14.5% | 26.0% |
每股收益（稀释后）CLCSX
| Q1 26 | $0.80 | — | ||
| Q4 25 | $-0.04 | $0.39 | ||
| Q3 25 | $0.91 | $0.37 | ||
| Q2 25 | $0.91 | $0.44 | ||
| Q1 25 | $0.85 | $0.34 | ||
| Q4 24 | $0.89 | $0.38 | ||
| Q3 24 | $0.90 | $0.46 | ||
| Q2 24 | $0.89 | $0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $1.1B |
| 总债务越低越好 | — | $18.9B |
| 股东权益账面价值 | — | $13.6B |
| 总资产 | $16.6B | $44.2B |
| 负债/权益比越低杠杆越低 | — | 1.39× |
8季度趋势，按日历期对齐
现金及短期投资CLCSX
| Q1 26 | $1.3B | $1.1B | ||
| Q4 25 | $1.4B | $5.0M | ||
| Q3 25 | $1.3B | $6.0M | ||
| Q2 25 | $1.2B | $6.0M | ||
| Q1 25 | $1.1B | $8.0M | ||
| Q4 24 | $1.3B | $72.0M | ||
| Q3 24 | $1.2B | $12.0M | ||
| Q2 24 | $1.1B | $4.0M |
总债务CLCSX
| Q1 26 | — | $18.9B | ||
| Q4 25 | $7.8B | $18.2B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $18.6B | ||
| Q1 25 | — | $18.5B | ||
| Q4 24 | $7.0B | $17.9B | ||
| Q3 24 | — | $18.5B | ||
| Q2 24 | — | $18.0B |
股东权益CLCSX
| Q1 26 | — | $13.6B | ||
| Q4 25 | $54.0M | $13.2B | ||
| Q3 25 | $856.0M | $12.8B | ||
| Q2 25 | $702.0M | $12.4B | ||
| Q1 25 | $363.0M | $12.2B | ||
| Q4 24 | $212.0M | $12.5B | ||
| Q3 24 | $435.0M | $12.9B | ||
| Q2 24 | $123.0M | $12.6B |
总资产CLCSX
| Q1 26 | $16.6B | $44.2B | ||
| Q4 25 | $16.3B | $43.7B | ||
| Q3 25 | $17.5B | $43.3B | ||
| Q2 25 | $17.5B | $42.9B | ||
| Q1 25 | $16.6B | $43.2B | ||
| Q4 24 | $16.0B | $42.8B | ||
| Q3 24 | $16.8B | $43.1B | ||
| Q2 24 | $16.5B | $42.4B |
负债/权益比CLCSX
| Q1 26 | — | 1.39× | ||
| Q4 25 | 145.17× | 1.38× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.52× | ||
| Q4 24 | 33.04× | 1.43× | ||
| Q3 24 | — | 1.43× | ||
| Q2 24 | — | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $609.0M | $793.0M |
| 自由现金流率自由现金流/营收 | 11.4% | 22.8% |
| 资本支出强度资本支出/营收 | 2.6% | — |
| 现金转化率经营现金流/净利润 | — | 1.58× |
| 过去12个月自由现金流最近4个季度 | $3.8B | $2.0B |
8季度趋势，按日历期对齐
经营现金流CLCSX
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $884.0M | $635.0M | ||
| Q1 25 | $600.0M | $1.3B | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | $1.2B | $1.7B | ||
| Q2 24 | $990.0M | $1.1B |
自由现金流CLCSX
| Q1 26 | $609.0M | $793.0M | ||
| Q4 25 | $1.3B | $709.0M | ||
| Q3 25 | $1.1B | $607.0M | ||
| Q2 25 | $776.0M | $-141.0M | ||
| Q1 25 | $476.0M | $536.0M | ||
| Q4 24 | $1.1B | $550.0M | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $873.0M | $547.0M |
自由现金流率CLCSX
| Q1 26 | 11.4% | 22.8% | ||
| Q4 25 | 24.4% | 20.2% | ||
| Q3 25 | 21.6% | 16.9% | ||
| Q2 25 | 15.2% | -3.9% | ||
| Q1 25 | 9.7% | 15.7% | ||
| Q4 24 | 21.9% | 15.5% | ||
| Q3 24 | 20.5% | 29.3% | ||
| Q2 24 | 17.3% | 14.8% |
资本支出强度CLCSX
| Q1 26 | 2.6% | — | ||
| Q4 25 | 3.4% | 19.3% | ||
| Q3 25 | 3.0% | 20.4% | ||
| Q2 25 | 2.1% | 21.7% | ||
| Q1 25 | 2.5% | 21.0% | ||
| Q4 24 | 3.7% | 23.7% | ||
| Q3 24 | 2.7% | 17.3% | ||
| Q2 24 | 2.3% | 14.6% |
现金转化率CLCSX
| Q1 26 | — | 1.58× | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.72× | 1.93× | ||
| Q2 25 | 1.19× | 0.77× | ||
| Q1 25 | 0.87× | 1.94× | ||
| Q4 24 | 1.72× | 1.93× | ||
| Q3 24 | 1.58× | 1.89× | ||
| Q2 24 | 1.35× | 1.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CL
| Latin America | $1.3B | 25% |
| Pet Nutrition | $1.2B | 22% |
| Europe, Middle East & Africa (1) | $1.1B | 21% |
| North America (1) | $888.0M | 17% |
| Asia Pacific (1) | $804.0M | 15% |
CSX
暂无分部数据
